NCT05947110

Brief Summary

This study was designed to assess the effect of an 8-week plyometric-based hydro-kinesio therapy (Plyo-HKT) on pain, muscle strength, postural control, and functional performance in a convenience sample of children with hemophilic knee arthropathy (HKA). Forty-eight patients with HKA were randomly allocated to the Plyo-HKT group (n = 24, received the plyometric-based hydro-kinesio therapy program, twice/week, over 8 weeks) or the control group (n = 24, received standard exercise program). Both groups were assessed for pain, muscle strength, postural control, and functional performance pre and post-treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 7, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
Last Updated

July 17, 2023

Status Verified

July 1, 2023

Enrollment Period

1.4 years

First QC Date

July 7, 2023

Last Update Submit

July 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain intensity

    Participants reported how much they feel pain during rest and/or movement on the 0-10 Numerical Pain Rating Scale, where 0 represents "no pain" and 10 indicates the "worst possible pain".

    2 months

  • Muscle strength

    Indicated by the peak concentric torque of the quadriceps and hamstring muscles (Nm). It was measured using an Isokinetic Dynamometer.

    2 months

  • Postural control

    The capacity to control and move the center of gravity in various directions across the base of support was assessed utilizing the Biodex balance system. Values are expressed as accuracy % and higher scores mean better balance capability.

    2 months

Secondary Outcomes (2)

  • Functional independence

    2 months

  • Six-minute walk test

    2 months

Study Arms (2)

Plyo-HKT group

EXPERIMENTAL

Participants in this group received the Plyo-HKT program

Other: Plyometric-based hydro-kinesio therapy

Control group

ACTIVE COMPARATOR

Participants in this group received the standard exercise program.

Other: Standard exercise therapy

Interventions

The plyometric-based hydro-kinesio therapy was conducted for 45 minutes, twice weekly, for 8 successive weeks. The training was geared toward the lower body and was conducted under the close supervision of a licensed pediatric physical therapist in accordance with the safety performance guidelines defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association.

Plyo-HKT group

The program encompassed the standard exercises for patients with JIA (aerobic, weight-bearing, proprioceptive, flexibility, and strengthening exercises). The training was conducted for 45 minutes, two times a week for 8 successive weeks.

Control group

Eligibility Criteria

Age8 Years - 16 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Eight and 16 years.
  • Had factor VIII replacement prophylaxis.
  • Clinically-stable.
  • Unilateral knee involvement.
  • Knee arthropathy of grade II or III per the Arnold-Hilgartner radiographic classification.
  • Muscle strength of grade 3 in lower limb muscles.
  • Use of no pain medication for one month prior to enrollment.
  • Walking independently.

You may not qualify if:

  • Enduring disabling pain
  • Fixed deformities.
  • History of musculoskeletal surgery.
  • Visual or vestibular deficits.
  • Engagement in regular exercises.
  • Bleeding episodes within two weeks prior to enrolment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ragab K. Elnaggar

Al Kharj, Riyadh Region, Saudi Arabia

Location

Study Officials

  • Ragab K Elnaggar, PhD

    Prince Sattam Bin Abdulaziz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This was a single-blind protocol. The researcher who collected the data was blinded to the treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective, randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 7, 2023

First Posted

July 17, 2023

Study Start

September 5, 2021

Primary Completion

January 26, 2023

Study Completion

January 26, 2023

Last Updated

July 17, 2023

Record last verified: 2023-07

Locations